Tandem Diabetes Care, Inc. reports results for the quarter ended June 30 - Earnings Summary

Tandem Diabetes Care

06/08/2026 22:39

Tandem Diabetes Care, Inc. TNDM.OQ reported a quarterly adjusted loss of 31 cents​​ per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of -48 cents.  The mean expectation of twenty one analysts for the quarter was for a loss of 32 cents per share. Wall Street expected results to range from -41 cents to -23 cents per share.
Revenue rose 5.8% to $254.56 million from a year ago; analysts expected $254.98 million. 
Tandem Diabetes Care, Inc.'s reported EPS for the quarter was a loss of 31 cents​.
The company reported a quarterly loss of $21.17 million.
Tandem Diabetes Care, Inc. shares had risen by 29.8% this quarter and lost 10.9% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts had fallen by about 9.4% in the last three months.​ 
In the last 30 days, two analysts negatively revised earnings estimates
RECOMMENDATIONS
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 12 "strong buy" or "buy," 10 "hold" and no "sell" or "strong sell." The average consensus recommendation for the medical equipment, supplies & distribution peer group is also "buy" 
Wall Street's median 12-month price target for Tandem Diabetes Care, Inc. is $28.00, about 30% above its last closing price of $19.59
This summary was machine generated from LSEG data August 6 at 09:39 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING
ESTIMATE 
ACTUAL
BEAT, MET, MISSED
Jun. 30 2026 
-0.32
-0.31
Beat
Mar. 31 2026 
-0.44
-0.30
Beat
Dec. 31 2025 
-0.08
-0.01
Beat
Sep. 30 2025 
-0.31
-0.31
Met